Lymphocytes are central for the regulation of an immune response. CD4+ T lymphocytes can differentiate to functionally distinct subsets and classified based on their cytokine secretion profiles as well as other properties. Proper regulation and balance between various lymphocyte subsets is central for the appropriate function of the immune system and required e.g. for host defence against pathogens or cancer as well as protection from autoimmune diseases. Recently, a new effector CD4+ T cell subset Th17 was discovered and named according to the main cytokine they secrete, IL17. Besides being involved in host defence to extracellular pathogens, Th17 cells play a central role in the pathogenesis of several autoimmune diseases such as rheumatoid arthritis, experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis, rheumatoid arthritis and others including inflammatory diseases in human and experimental mouse models.
The cellular response to an external stimulus is mediated through a series of overlapping networks that include the signalling network,and transcription factor control at genome level, and the gene regulatory network where e.g. miRNAs and alternatively splicing play an important role. In this project we will study these networks during the differentiation of Th17 cells combining genome-wide experimental and computational approaches. We expect that our project results in the identification of the key regulatory components and hubs, or the pathways that they participate in, which may provide targets for rational chemotherapy either for the immune-mediated diseases described above, or for enhancing protective immunity against infectious agents. Our multidisciplinary consortium provides cutting-edge complementary expertise to achieve the goals.
MRC National Institute for Medical Research London, UK »website
Tampere University of Technology, FI »website
The Netherlands Cancer Institute Amsterdam, NL »website
© Projektträger JülichOnline 2006
Alle Rechte vorbehalten